United States · FDA National Drug Code directory
Everolimus
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0093-7768_0f7ea770-928b-43b2-8971-849d1d12bbc8
- Product NDC
- 0093-7768
- Form
- TABLET
- Composition / generic term
- Everolimus
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200610 / 20260930
Source-listed ingredients
- EVEROLIMUS — 7.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 28 BLISTER PACK in 1 CARTON (0093-7768-24) / 1 TABLET in 1 BLISTER PACK (0093-7768-19) · 0093-7768-24
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →